Low-molecular weight heparins in coronary artery disease (original) (raw)
Comparison of low-molecular weight heparins to unfractionated heparin
Robert Berent
European Heart Journal, 2001
View PDFchevron_right
Unfractionated versus low-molecular-weight heparin in the treatment of venous thromboembolism
menab men
View PDFchevron_right
Low-molecular-weight heparin (LMWH) in the treatment of thrombosis
René G Holzheimer
European journal of medical research, 2004
View PDFchevron_right
Use of Low-Molecular-Weight Heparins in the Management of Acute Coronary Artery Syndromes and Percutaneous Coronary Intervention
Graham Wong
JAMA, 2003
View PDFchevron_right
Update of the recommendations on biosimilar low-molecular-weight heparins from the Scientific Subcommittee on Control of Anticoagulation of the International Society on Thrombosis and Haemostasis
Giangiacomo Torri
Journal of Thrombosis and Haemostasis
View PDFchevron_right
Prevention of arterial thrombosis using a novel heparin with enhanced antiplatelet activity and reduced anticoagulant activity
Robert F Harris
Journal of Vascular Surgery, 1997
View PDFchevron_right
Pharmacological and clinical evidence for the use of low-molecular-weight heparins in acute coronary syndromes
Guido Rosito
Arquivos Brasileiros de Cardiologia, 2001
View PDFchevron_right
Evaluation of a New Heparin Agent in Percutaneous Coronary Intervention: Results of the Phase 2 Evaluation of M118 IN pErcutaNeous Coronary intErvention (EMINENCE) Trial
Roger Gammon
Circulation, 2010
View PDFchevron_right
Combinations of Low Doses of Unfractionated Heparin and of Low-Molecular-Weight Heparin Prevent Experimental Venous Thrombosis
Francisco Humberto De Abreu Maffei
Pathophysiology of Haemostasis and Thrombosis, 2005
View PDFchevron_right
Low-molecular-weight heparin alone versus a combination of unfractionated heparin and low-molecular-weight heparin
Alberto Quispe
American Heart Journal, 2000
View PDFchevron_right
Another bleeding heart: perioperative heparin management revisited
Christopher Harle
Canadian Journal of Anesthesia/Journal canadien d'anesthésie, 2007
View PDFchevron_right
Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety
James Dalen
Chest, 1992
View PDFchevron_right
Low-Molecular-Weight Heparins for the Prevention and Treatment of Venous Thromboembolism
Gia Dice
Military Medicine, 2001
View PDFchevron_right
Low-molecular-weight heparin for thromboprophylaxis
Giuseppe Camporese
Current opinion in pulmonary medicine, 2009
View PDFchevron_right
Low-molecular-weight heparins in acute myocardial infarction: RationaLe and results of a pilot study
Karin Coyne
Clinical Cardiology, 2000
View PDFchevron_right
The role of low molecular weight heparin (LMWH) in acute thrombosis (stroke and acute coronary syndrome)
shufrie effendy
2004
View PDFchevron_right
A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease
Jerome Premmereur
The New England Journal of Medicine, 1997
View PDFchevron_right
Low-Molecular-Weight Heparin in the Treatment of Patients With Venous Thromboembolism
Jack Hirsh
The Journal of Urology, 1998
View PDFchevron_right
Antithrombotic and bleeding effects of a low molecular weight heparin fraction
Giangiacomo Torri
Biochemical Pharmacology, 1985
View PDFchevron_right
Low-molecular-weight heparins in non–ST-segment elevation ischemia: the ESSENCE trial
Jerome Premmereur
The American Journal of Cardiology, 1998
View PDFchevron_right
Low-molecular-weight heparin vs. unfractionated heparin in percutaneous coronary intervention: A combined analysis
Jean-sébastien Hulot
Catheterization and Cardiovascular Interventions, 2005
View PDFchevron_right
Comparative effectiveness of low-molecular-weight heparin versus unfractionated heparin for thromboembolism prophylaxis for medical patients
Soyon Lee
Journal of Hospital Medicine, 2012
View PDFchevron_right
PROPHYLAXIS OF THROMBOSIS WITH LOW-MOLECULAR-WEIGHT HEPARIN (LMWH
René G Holzheimer
eur j med res, 2004
View PDFchevron_right
Role of Low-Molecular-Weight Heparin in Invasive Management of Non-ST-Elevation Acute Coronary Syndromes
Lynette Moser
Annals of Pharmacotherapy, 2004
View PDFchevron_right
Preclinical studies on a low molecular weight heparin
Ahmad ridhani ahsan
Thrombosis Research, 1996
View PDFchevron_right
Low-Molecular-Weight Heparins: Are they all the Same?
Jeffrey Ginsberg
British Journal of Haematology, 2003
View PDFchevron_right
Low molecular weight heparin versus unfractionated heparin in the initial treatment of venous thromboembolism
Martin Prins
Current Opinion in Pulmonary Medicine, 1998
View PDFchevron_right
Monitoring of low-molecular-weight heparins in cardiovascular disease
R. Abbate, Guglielmina Pepe
The American Journal of Cardiology, 1998
View PDFchevron_right
Secondary Prevention of Venous Thromboembolism: A Role for Low-Molecular-Weight Heparin
Manuel Monreal
Pathophysiology of Haemostasis and Thrombosis, 1998
View PDFchevron_right
Low molecular weight heparin in prevention of perioperative thrombosis
Francois Chapuis
BMJ, 1992
View PDFchevron_right
Low molecular weight heparin (dalteparin) is equally effective as unfractionated heparin in reducing coagulation activity and perfusion abnormalities during the early treatment of pulmonary embolism
Fred Verzijlbergen
2004
View PDFchevron_right
Randomised controlled trial for efficacy of unfractionated heparin (UFH) versus low molecular weight heparin (LMWH) in thrombo-prophylaxis
shailesh kakde
PubMed, 2013
View PDFchevron_right
Heparins: Clinical use and laboratory monitoring
Julia Davis
Laboratory Medicine, 2010
View PDFchevron_right